Fusion Antibody Share News (FAB)

Fusion Antibody Information

Buy FAB Shares
Add FAB to Watchlist
Add FAB to Alert

Share Price Information for Fusion Antibody (FAB)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 3.80

Bid: 3.70

Ask: 3.90

Change: 0.15 (4.11%)

Spread: 0.20 (5.405%)

Open: 3.65

High: 3.80

Low: 3.65

Prev. Close: 3.65

Last checked at -

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

Fri, 18th Sep 2020 21:16

Fusion Antibodies PLC - pharmaceutical company based in Belfast - Says proof-of-concept on Mammalian Antibody Library Discovery Platform, Covid-19 related research. Fusion Antibodies says "progress" being made on design of SARS-CoV-2 proteins as it looks to develop antigens to fight against virus. Stock more than doubled on Friday.

Current stock price: 222.67 pence

Year-to-date change: up sharply from 78.50p

By Eric Cunha; ericcunha@alliancenews.com

More News

4 May 2021 19:13

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

16 Feb 2021 14:24

IN BRIEF: Fusion Antibodies Hires Jones From BrYet To Replace CEO Kerr

11 Feb 2021 11:16

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

20 Nov 2020 13:25

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

13 Nov 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

27 Oct 2020 15:15

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

24 Sep 2020 16:35

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

18 Sep 2020 15:45

UK Shareholder Meetings Calendar - Next 7 Days

18 Sep 2020 09:48

Fusion Antibodies soars on Covid-19 test progress

(Sharecast News) - Fusion Antibodies shares soared after the antibody specialist said it had made progress on developing coronavirus antigen tests.

19 Aug 2020 09:15

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

11 Aug 2020 12:36

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

6 Jul 2020 16:02

IN BRIEF: Fusion Antibodies Expects Revenue Surge Amid Pandemic

6 Jul 2020 10:41

Fusion Antibodies FY revenues continue to grow in 2020

(Sharecast News) - Pre-clinical antibodies group Fusion Antibodies said on Monday that revenues had continued to grow over the year ending on 31 March.

28 Apr 2020 12:28

Latest Share Chat

Fusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

IN BRIEF: Fusion Antibodies Hires Jones From BrYet To Replace CEO Kerr

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

UK Earnings, Trading Statements Calendar - Next 7 Days

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

UK Shareholder Meetings Calendar - Next 7 Days

Fusion Antibodies soars on Covid-19 test progress

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

IN BRIEF: Fusion Antibodies Expects Revenue Surge Amid Pandemic

Fusion Antibodies FY revenues continue to grow in 2020

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Latest Share Chat

Fusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

Login to your account

Quickpicks are a member only feature

Login to your account